The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Scaling volumes help CPV gain credibility

December 23, 2010 11:34 pm | by I-Micronews | News | Comments

The ramp of serious volume manufacturing capability from more concentrating photovoltaics suppliers, and a host of creative solutions to some of the nagging issues long dogging the technology, could start to make CPV a more serious contender in the PV market.

Tokyo Stock Exchange: closing price list -8-+

December 23, 2010 8:45 pm | by The Associated Press | News | Comments

TSEPrices UP/DN Stanley Elec Co1539 DN4 SUMCO Corp1190 UP 25 Sumitomo Chem Co385 DN3 Sumitomo Corp1155 DN 10 Sumitomo Elec Ind1120 DN9 Sumitomo HI Ltd527 DN2 Sumitomo Metal Ind201 DN1 Sumitomo Metal Min1421 DN5 Sumitomo Mitsui Fin2888 DN 23 Sumitomo Osaka Cem190 DN6 ...

VC-backed Vedanta to target cancer via 'good' bacteria

December 23, 2010 10:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Venture capital firm PureTech Ventures is launching a new company, called Vedanta Biosciences, to commercialize research newly published today in the academic journal Science that indicates beneficial, gut-dwelling bacteria may also be useful for combating allergies and inflammatory bowel disease.


Made in IBM Labs: Scientific Discovery Moves Racetrack Memory Closer to Reality

December 23, 2010 10:32 am | by IBM | News | Comments

IBM Researchers today revealed a previously unknown aspect of key physics inside Racetrack memory -- a new technology design which stands to improve memory capabilities within mobile phones, laptop computers and business-class servers. This new class of memory could enable devices to...

Biogen Idec, Elan apply for MS drug label update

December 23, 2010 9:38 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Biogen Idec Inc. and Elan Corp. plc, the co-owners of multiple sclerosis drug Tysabri, have sent a recommendation to the U.S. Food and Drug Administration and the European Medicines Agency to update the labeling of the drug in order to clarify the risk of a rare but potentially fatal...


ACT seeks orphan drug status in Europe for vision loss treatment

December 23, 2010 9:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Advanced Cell Technology Inc. has filed in Europe for Orphan Drug Designation for its retinal epithelial (RPE) cells to treat Stargardt's Macular Dystrophy (Stargardt's Disease), according to a news release today.

Pathfinder, SyntheMed merge

December 23, 2010 9:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Pathfinder LLC, a private Cambridge cell-based therapeutics firm, and New Jersey biomaterials firm SyntheMed Inc. have merged, the two companies announced Wednesday. The newly formed company will be called Pathfinder Cell Therapy Inc. and have its headquarters in Cambridge.

Significant improvement in LED fundamental and manufacturing technologies needed for massive adoption in general lighting applications

December 23, 2010 7:32 am | by I-Micronews | News | Comments

Yole Développement (Lyon, France) and EPIC (Paris, France) announce the publication of their new market & technological study dedicated to LED industry: LED ManTech Report.


New CVS Caremark Study Finds Health Information Technology May Help Promote Adherence, But More Information and Direction Needed

December 23, 2010 7:31 am | by Bio-Medicine.Org | News | Comments

WOONSOCKET, R.I., Dec. 23, 2010 /- A new study that reviews more than four decades of medical journal articles about the impact of health information technology (HIT) and electronic communications on medication adherence concludes that while there is evidence to suggest that simple...


Cannabis Science Forms Military Advisory Board That Will Be Comprised of Distinguished Military Leaders, Military Health Care Providers, Researchers and Educators Headed Up by...

December 23, 2010 7:31 am | by Bio-Medicine.Org | News | Comments

COLORADO SPRINGS, Colo., Dec. 23, 2010 /- Cannabis Science, Inc. (OTC Bulletin Board: CBIS ), a pioneering U.S. biotech company developing pharmaceutical cannabis products, announced today that it has formed a Military Advisory Board, that will be comprised of distinguished military...


BioRelix lands $2.4M financing

December 23, 2010 6:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

BioRelix Inc., a New Haven, Conn.-based biotech focused on developing infectious disease treatments, has taken in $2.4 million of a planned $4.8 million debt and warrants financing, according to a regulatory filing.

Fruta Planta: Public Notification - Undeclared Drug Ingredient

December 23, 2010 6:31 am | by U.S. Food & Drug Administration | News | Comments

Product marketed as a dietary supplement contains sibutramine, a controlled substance known to substantially increase blood pressure and/or pulse rate, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke.


RockHard Weekend, Pandora: Recall - Undeclared Drug Ingredient

December 23, 2010 6:30 am | by U.S. Food & Drug Administration | News | Comments

Product marketed as dietary supplement contains undeclared analogue of sildenafil, a drug which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.


Bench Oven Cures Medical Instruments

December 23, 2010 5:26 am | The Grieve Corporation | Product Releases | Comments

No. 983 is an electrically-heated 550°F bench oven from Grieve, currently used for curing medical instruments. The 3 KW are installed in Incoloy sheathed tubular heating elements. Workspace dimensions are 26 in. wide x 22 in. deep x 16 in. high.

Pushbutton Switch has a 50,000,000 Life Cycle Expectancy

December 23, 2010 5:19 am | Product Releases | Comments

E-Switch announces the LP16 series long life, illuminated pushbutton switch. Its long life of 50,000,000 cycles is realized by the help of magnets.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.